Geron | GERN - Market Capitalization


Geron reported $952.1M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 209.65B 14.21B Aug/2026
Bio Techne USD 8.18B 987M Mar/2026
Cassava Sciences USD 82M 14M Mar/2026
Cytokinetics USD 8.19B 420M Mar/2026
Exelixis USD 16.09B 5.2B Aug/2026
Genmab DKK 20.48B 1.02B Dec/2025
Geron USD 952M 3M Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025